Comparison of technetium-99m-sestamibi scintimammography with contrast- enhanced MRI for diagnosis of breast lesions

Journal of Nuclear Medicine

Volumn 38, Issue 1, 1997, Pages 58-62

  Tiling, Reinhold ^a,b   Sommer, Harald ^a   Pechmann, Martina ^a   Moser, Ruth ^a   Kress, Katharina ^a   Pfluger, Thomas ^a   Tatsch, Klaus ^a   Hahn, Klaus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

breast cancer; contrast enhanced MRI; scintimammography; technetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PENTETIC ACID;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTIGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; TECHNETIUM TC 99M SESTAMIBI;

EID: 0031022468     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Berg JW, Hutter RV. Breast cancer. Cancer 1995;75:257-269.
2. MMWR. Deaths from breast cancer - United States, 1991. Morb Mortal Wkly Rep 1994;43:273,279-281.
3. Sondik EJ. Breast cancer trends. Incidence, mortality and survival. Cancer 1994;74: 995-999.
4. Simon MS, Lemamme D, Schwartz AG, Martino S, Swanson GM. Recent trends in the incidence of in situ and invasive breast cancer in the Detroit metropolitan area (1975-1988). Cancer 1993;71:769-774.
5. Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 1991;2:67-74.
6. Sickles EA. Mammographic feature of 300 consecutive nonpalpable breast cancers. Am J Roentgenol 1986;146:661-663.
7. Bird RE, Wallace TW, Yankanskas BC. Analysis of cancer missed at the screening mammography. Radiology 1992;184:613-617.
8. Jackson VP, Hendrick RE, Kerg SA, et al. Imaging of the radiographically dense breast. Radiology 1993;198:297-301.
9. Kopans DB. Positive predictive value of mammography. Am J Roentgenol 1992;158: 521-526.
10. Humphry LL, Ballard DJ. Early detection of breast cancer in women. Prev Pract 1989;16:115-132.
11. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994;29:94-104.
12. Wiener JI, Chako AC, Merten CW, et al. Breast and axillary tissue MR imaging: correlations of signal intensities and relaxation times with pathologic findings. Radiology 1986;160:299-305.
13. Alcorn FS, Turner DA, Clark JW, et al. Magnetic resonance imaging in the study of the breast. Radiographics 1985;5:631-652.
14. Adler DD, Wahl RL. New methods for imaging the breast: techniques, findings and potential. Am J Roentgenol 1995;164:19-30.
15. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation of resonance: clinical experience with pathologic correlation. Radiology 1993;187:493-501.
16. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995;196:143-152.
17. Harms SE, Flamig DP, Evans WP, Harries SA, Bown S. MR imaging of the breast: current status and future potential. Am J Roentgenol 1994;163:1039-1047.
18. Stelling CB. Breast cancer staging with contrast material-enhanced MR imaging: should it change patient treatment? Radiology 1995;196:16-18.
19. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995;196:593-610.
20. 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604-612.
21. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m-methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-436.
22. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m-sestamibi. Eur J Nucl Med 1994;21:357-362.
23. 99mTc-sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
24. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
25. Lastoria S, Varella P, Mainolfi C, et al. Technetium-99m-sestamibi scintigraphy in the diagnosis of primary breast cancer [Abstract]. J Nucl Med 1994;35:22.
26. Palmedo H, Schomburg A, Grünwald F, Mallmann P, Krebs D, Biersack HJ. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-630.
27. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
28. 99mTc-sestamibi imaging versus dynamic MRI [Abstract]. J Nucl Med 1995;36:51.
29. 99mTc-MIBI in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpalpable lesions with mammography [Abstract]. J Nucl Med 1994;35:22.
30. Harms SE, Flamig DP, Hesley KL, et al. Fat-suppressed three dimensional MR imaging of the breast. Radiographics 1993;13:247-267.
31. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with or without Gd-DTPA. Radiology 1989;170:681-686.
32. Heywang SA, Wolf A, Pruss E, et al. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989;171:95-103.
33. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994;191:625-631.
34. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986;10:199-204.
35. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterisation with Gd-DTPA enhancement profiles. Radiology 1990;174:491-494.
36. Revel D, Brasch R, Paajanen H, et al Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology 1986;158: 319-323.
37. Orel SG, Schnall MD, Livolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994;190:485-493.
38. 99mTc-MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516-1521.
39. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblast. J Nucl Med 1990;31:1646-1653.
40. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisonitrile) technetium-99m complexes. J Nucl Med 1989;31:1166-1167.